+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

  • PDF Icon

    Report

  • 124 Pages
  • May 2026
  • Region: Asia Pacific
  • GlobalData
  • ID: 6115086

Asia-Pacific Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

Summary

The analyst’s “Asia-Pacific Cardiac Disease Market Outlook to 2036” is a comprehensive databook report, covering key market data on the Asia-Pacific Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The Asia-Pacific Cardiac Disease Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Cardiac Disease is segmented as follows:

  • Cardiac Marker Tests

Reasons to Buy

The Asia-Pacific Cardiac Disease Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Disease Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Disease Market, Asia-Pacific
2.1 Cardiac Disease Market, Asia-Pacific, Revenue ($m), 2024-2036
2.2 Cardiac Disease Market, Asia-Pacific, Revenue ($m), 2024-2036
2.3 Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
2.4 Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
2.5 Cardiac Disease Market, Asia-Pacific, Company Share by Revenue ($m), 2025
3 Cardiac Disease Market, Australia
3.1 Cardiac Disease Market, Australia, Revenue ($m), 2024-2036
3.1.1 Cardiac Marker Tests Market, Australia, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Disease Market, Australia, Volume (Units), 2024-2036
3.2.1 Cardiac Marker Tests Market, Australia, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Disease Market, Australia, Average Price ($), 2024-2036
3.4 Cardiac Disease Market, Australia, Company Share by Revenue ($m), 2025
4 Cardiac Disease Market, China
4.1 Cardiac Disease Market, China, Revenue ($m), 2024-2036
4.1.1 Cardiac Marker Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Disease Market, China, Volume (Units), 2024-2036
4.2.1 Cardiac Marker Tests Market, China, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Disease Market, China, Average Price ($), 2024-2036
4.4 Cardiac Disease Market, China, Company Share by Revenue ($m), 2025
5 Cardiac Disease Market, India
5.1 Cardiac Disease Market, India, Revenue ($m), 2024-2036
5.1.1 Cardiac Marker Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Disease Market, India, Volume (Units), 2024-2036
5.2.1 Cardiac Marker Tests Market, India, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Disease Market, India, Average Price ($), 2024-2036
5.4 Cardiac Disease Market, India, Company Share by Revenue ($m), 2025
6 Cardiac Disease Market, Japan
6.1 Cardiac Disease Market, Japan, Revenue ($m), 2024-2036
6.1.1 Cardiac Marker Tests Market, Japan, Revenue ($m), by Segment, 2024-2036
6.2 Cardiac Disease Market, Japan, Volume (Units), 2024-2036
6.2.1 Cardiac Marker Tests Market, Japan, Volume (Units), by Segment, 2024-2036
6.3 Cardiac Disease Market, Japan, Average Price ($), 2024-2036
6.4 Cardiac Disease Market, Japan, Company Share by Revenue ($m), 2025
7 Cardiac Disease Market, South Korea
7.1 Cardiac Disease Market, South Korea, Revenue ($m), 2024-2036
7.1.1 Cardiac Marker Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
7.2 Cardiac Disease Market, South Korea, Volume (Units), 2024-2036
7.2.1 Cardiac Marker Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
7.3 Cardiac Disease Market, South Korea, Average Price ($), 2024-2036
7.4 Cardiac Disease Market, South Korea, Company Share by Revenue ($m), 2025
8 Cardiac Disease Market Pipeline Products
8.1 Cardiac Disease Market Pipeline Products
8.2 Cardiac Disease - Pipeline Products by Stage of Development
8.3 Cardiac Disease - Pipeline Products by Segment
8.4 Cardiac Disease - Pipeline Products by Territory
8.5 Cardiac Disease - Pipeline Products by Regulatory Path
8.6 Cardiac Disease - Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in Asia-Pacific Cardiac Disease Market
9.1 F. Hoffmann-La Roche Ltd
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Siemens Healthineers AG
9.3.1 Company Overview
9.4 Quidel Corp
9.4.1 Company Overview
9.5 Beckman Coulter Inc
9.5.1 Company Overview
9.6 bioMerieux SA
9.6.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Oct 21, 2025: University of Paris-Saclay Establishes New Strategic Orientation Council Led by Geneviève Berger
10.2 Product News
10.2.1 Mar 12, 2026: PsyMetRiC: Tool to Predict Physical Health Risks in Young People With Psychosis
10.2.2 Feb 12, 2026: HRS Releases Scientific Statement on Pulsed Field Ablation for Cardiac Arrhythmias
10.2.3 Nov 13, 2025: New Gene Discoveries Enhance Diagnosis of Inherited Heart Disease
10.2.4 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications
10.2.5 Jul 24, 2025: Japan Medical Device: Our efforts were introduced on the RIKEN website
10.3 Strategy And Business Planning
10.3.1 Jul 01, 2025: KarisBio and MEPSGEN to Collaborate on 3D Cardiovascular Tissue Model Using iPSC and MPS
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Disease Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
Table 4: Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
Table 5: Cardiac Disease Market, Asia-Pacific, Company Share by Revenue ($m), 2025
Table 6: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 8: Cardiac Disease Market, Australia, Volume (Units), 2024-2036
Table 9: Cardiac Marker Tests Market, Australia, Volume (Units), 2024-2036
Table 10: Cardiac Disease Market, Australia, Average Price ($), 2024-2036
Table 11: Cardiac Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2025
Table 12: Cardiac Disease Market, China, Revenue ($m), USD Constant, 2024-2036
Table 13: Cardiac Marker Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 14: Cardiac Disease Market, China, Volume (Units), 2024-2036
Table 15: Cardiac Marker Tests Market, China, Volume (Units), 2024-2036
Table 16: Cardiac Disease Market, China, Average Price ($), 2024-2036
Table 17: Cardiac Disease Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 18: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2024-2036
Table 19: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Disease Market, India, Volume (Units), 2024-2036
Table 21: Cardiac Marker Tests Market, India, Volume (Units), 2024-2036
Table 22: Cardiac Disease Market, India, Average Price ($), 2024-2036
Table 23: Cardiac Disease Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 24: Cardiac Disease Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 25: Cardiac Marker Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 26: Cardiac Disease Market, Japan, Volume (Units), 2024-2036
Table 27: Cardiac Marker Tests Market, Japan, Volume (Units), 2024-2036
Table 28: Cardiac Disease Market, Japan, Average Price ($), 2024-2036
Table 29: Cardiac Disease Market, Japan, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Cardiac Disease Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 31: Cardiac Marker Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 32: Cardiac Disease Market, South Korea, Volume (Units), 2024-2036
Table 33: Cardiac Marker Tests Market, South Korea, Volume (Units), 2024-2036
Table 34: Cardiac Disease Market, South Korea, Average Price ($), 2024-2036
Table 35: Cardiac Disease Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Cardiac Disease Market Pipeline Products
Table 37: Cardiac Disease - Pipeline Products by Stage of Development
Table 38: Cardiac Disease Companies - Pipeline Products by Stage of Development
Table 39: Cardiac Disease - Pipeline Products by Segment
Table 40: Cardiac Disease - Pipeline Products by Territory
Table 41: Cardiac Disease - Pipeline Products by Regulatory Path
Table 42: Cardiac Disease - Pipeline Products by Estimated Approval Date
Table 43: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Disease Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 4: Cardiac Disease Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 5: Cardiac Disease Market, Asia-Pacific, Company Share (%), 2025
Figure 6: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 8: Cardiac Disease Market, Australia, Volume (Units), 2024-2036
Figure 9: Cardiac Marker Tests Market, Australia, Volume (Units), 2024-2036
Figure 10: Cardiac Disease Market, Australia, Company Share (%), 2025
Figure 11: Cardiac Disease Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 12: Cardiac Marker Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 13: Cardiac Disease Market, China, Volume (Units), 2024-2036
Figure 14: Cardiac Marker Tests Market, China, Volume (Units), 2024-2036
Figure 15: Cardiac Disease Market, China, Company Share (%), 2025
Figure 16: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 17: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 18: Cardiac Disease Market, India, Volume (Units), 2024-2036
Figure 19: Cardiac Marker Tests Market, India, Volume (Units), 2024-2036
Figure 20: Cardiac Disease Market, India, Company Share (%), 2025
Figure 21: Cardiac Disease Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 22: Cardiac Marker Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 23: Cardiac Disease Market, Japan, Volume (Units), 2024-2036
Figure 24: Cardiac Marker Tests Market, Japan, Volume (Units), 2024-2036
Figure 25: Cardiac Disease Market, Japan, Company Share (%), 2025
Figure 26: Cardiac Disease Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 27: Cardiac Marker Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cardiac Disease Market, South Korea, Volume (Units), 2024-2036
Figure 29: Cardiac Marker Tests Market, South Korea, Volume (Units), 2024-2036
Figure 30: Cardiac Disease Market, South Korea, Company Share (%), 2025
Figure 31: Cardiac Disease - Pipeline Products by Stage of Development
Figure 32: Cardiac Disease - Pipeline Products by Segment
Figure 33: Cardiac Disease - Pipeline Products by Territory
Figure 34: Cardiac Disease - Pipeline Products by Regulatory Path
Figure 35: Cardiac Disease - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Quidel Corp
  • Beckman Coulter Inc
  • bioMerieux SA